PLx Pharma Winddown Corp.: 10-Q filed 2018-08-10

Name: PLx Pharma Winddown Corp.: 10-Q filed 2018-08-10
Creator: PLx Pharma Winddown Corp.

What PLx Pharma Winddown Corp. reported in its quarterly report filed 2018-08-10 (fiscal Q2 2018): 35 published measures, 92 facts as tagged in accession 0001437749-18-015162.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-08-10
Fiscal period: fiscal Q2 2018
Accession: 0001437749-18-015162 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PLx Pharma Winddown Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-06-30	22,862,351	USD
At 2017-12-31	28,848,573	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-06-30	16,308,171	USD
At 2017-12-31	24,232,181	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-06-30	6,554,180	USD
At 2017-12-31	4,616,392	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2018-06-30	17,924,709	USD
At 2017-12-31	24,404,368	USD
At 2017-06-30	25,079,590	USD
At 2016-12-31	59,335	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-3,603,404	USD	91
2018-01-01 to 2018-06-30	1,375,188	USD	181
2017-04-01 to 2017-06-30	-2,236,107	USD	91
2017-01-01 to 2017-06-30	-3,663,074	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	-5,813,931	USD	181
2017-01-01 to 2017-06-30	-5,932,813	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	665,728	USD	181
2017-01-01 to 2017-06-30	90,513	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	167,459	USD	91
2018-01-01 to 2018-06-30	248,916	USD	181
2017-04-01 to 2017-06-30	375,951	USD	91
2017-01-01 to 2017-06-30	375,951	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	19,267,154	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	-665,728	USD	181
2017-01-01 to 2017-06-30	11,685,914	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-06-30	-65,957,060	USD
At 2017-12-31	-67,332,248	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	8,729,962	shares	91
2018-01-01 to 2018-06-30	8,727,514	shares	181
2017-04-01 to 2017-06-30	6,157,970	shares	91
2017-01-01 to 2017-06-30	5,275,603	shares	181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	8,729,962	shares	91
2018-01-01 to 2018-06-30	8,727,514	shares	181
2017-04-01 to 2017-06-30	6,157,970	shares	91
2017-01-01 to 2017-06-30	5,275,603	shares	181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-0.41	USD/shares	91
2018-01-01 to 2018-06-30	0.16	USD/shares	181
2017-04-01 to 2017-06-30	-0.36	USD/shares	91
2017-01-01 to 2017-06-30	-0.69	USD/shares	181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-0.41	USD/shares	91
2018-01-01 to 2018-06-30	0.16	USD/shares	181
2017-04-01 to 2017-06-30	-0.36	USD/shares	91
2017-01-01 to 2017-06-30	-0.69	USD/shares	181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-920,000	USD	91
2017-01-01 to 2017-06-30	-920,000	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-06-30	1,516,594	USD
At 2017-12-31	1,029,875	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	517,600	USD	181
2017-01-01 to 2017-06-30	391,270	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-2,397,373	USD	91
2018-01-01 to 2018-06-30	-5,634,952	USD	181
2017-04-01 to 2017-06-30	-4,275,003	USD	91
2017-01-01 to 2017-06-30	-5,620,413	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-06-30	19,217,021	USD
At 2017-12-31	25,689,962	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-06-30	2,101,071	USD
At 2017-12-31	1,815,691	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2018-06-30	2,061,022	USD
At 2017-12-31	2,061,022	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	2,564,832	USD	91
2018-01-01 to 2018-06-30	5,883,868	USD	181
2017-04-01 to 2017-06-30	4,650,954	USD	91
2017-01-01 to 2017-06-30	5,996,364	USD	181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2017-12-31	246,374	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	734,246	USD	91
2018-01-01 to 2018-06-30	1,813,282	USD	181
2017-04-01 to 2017-06-30	626,296	USD	91
2017-01-01 to 2017-06-30	754,635	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-06-30	8,731,756	shares
At 2017-12-31	8,722,823	shares

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-06-30	130,253	USD
At 2017-12-31	141,707	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-3,603,404	USD	91
2018-01-01 to 2018-06-30	1,375,188	USD	181
2017-04-01 to 2017-06-30	-3,156,107	USD	91
2017-01-01 to 2017-06-30	-4,583,074	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	1,830,586	USD	91
2018-01-01 to 2018-06-30	4,070,586	USD	181
2017-04-01 to 2017-06-30	4,024,658	USD	91
2017-01-01 to 2017-06-30	5,241,729	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	89,451	USD	181
2017-01-01 to 2017-06-30	3,161	USD	181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-1,206,031	USD	91
2018-01-01 to 2018-06-30	7,010,140	USD	181
2017-04-01 to 2017-06-30	1,118,896	USD	91
2017-01-01 to 2017-06-30	1,037,339	USD	181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	-920,000	USD	181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	325,313	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	108,204	USD	181
2017-01-01 to 2017-06-30	375,951	USD	181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	229,043	USD	181
2017-01-01 to 2017-06-30	278,014	USD	181

Inspect the source

Entity: PLx Pharma Winddown Corp. / CIK 0001497504
Captured: 2026-09-22 19:50 UTC
SEC response SHA-256: d5fa1894253c4a7ca3d44f3b07f2263d07de14ac7e8983994cead4448c203364

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001497504.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))